Sandoz: stock shines on Deutsche Bank upgrade

(CercleFinance.com) - Sandoz shares rose on the Zurich stock exchange on Wednesday following an upgrade by Deutsche Bank, which has an optimistic outlook for the biosimilar drugmaker.


At noon, the share price was up 3.3%, after rising by almost 4%, outperforming the SMIM Swiss mid-cap index (+1.1%).

This morning, Deutsche Bank upgraded the stock from hold to buy, also raising its target price from 36 CHF to 42 CHF, representing 17% upside potential.

In addition to the planned launch of several new biosimilars and the promise of improved margins, analysts believe that the sales growth target of around 5% in 2025 could prove to be cautious, given the group's solid track record since its split from Novartis.


Copyright (c) 2025 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.